Please Wait
Applying Filters...
Menu
Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 1Coral Drugs Private Limited New Delhi IN

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

PharmaCompass
  • fda
  • EDQM
  • WHO-GMP

Virtual BoothCoral's API range includes Corticosteroids, Antihistamines. Hormones and Antineoplastics.

R1-CEP 2005-055 - Rev 03
Valid
Chemical
2020-09-25
1750
Corel Drugs cGMP partner for APIs

01

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothCoral's API range includes Corticosteroids, Antihistamines. Hormones and Antineoplastics.

Certificate Number : R1-CEP 2005-055 - Rev 03

Status : Valid

Issue Date : 2020-09-25

Type : Chemical

Substance Number : 1750

Corel Drugs cGMP partner for APIs

Looking for Certificates of Suitability (CEPs) for R1-CEP 2005-055 - Rev 03 of Coral Drugs Private Limited New Delhi In

Looking for Certificates of Suitability (CEPs) for R1-CEP 2005-055 - Rev 03 of Coral Drugs Private Limited New Delhi In 1

20

Coral Drugs Private Limited New Delhi In, based in India, is a pharmaceutical company that stands out with its certifications from FDA, EDQM and WHO-GMP.

They are recognized for Coral's API range includes Corticosteroids, Antihistamines. Hormones and Antineoplastics.

One of their significant offerings is Fluticasone propionate, supported by a 'Valid' Certificate of Suitability (CEP) with the number R1-CEP 2005-055 - Rev 03

This Chemical Type CEP, issued on September 25, 2020, remains in force until January 01, 1970, ensuring its reliability within the pharmaceutical industry.

Substance Number 1750 associated with this CEP further emphasizes